Rand firms on Covid-19 vaccine hopes
US-China tension and rising virus cases seem to have little effect on dampening the mood for now
15 July 2020 - 13:14
The rand was firmer on Wednesday, in line with its emerging-market peers, as progress in the development of a Covid-19 vaccine boosted investor risk appetite.
The US pharmaceutical company Moderna reported progress in the development of a Covid-19 vaccine, saying that the vaccine produced antibiotics to the coronavirus in all patients tested in an initial safety trial. The findings raised hopes that a vaccine could be brought to market quickly...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.